Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma

Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma

Background: There is a clear need to improve the efficiency of therapeutic strategy for patients with newly diagnosed glioblastoma (GBM). The purpose of this study was to evaluate the feasibility of hypofractionated intensity-modulated radiation therapy (IMRT), temozolomide and granulocyte-macrophag...

Full description

Saved in:
Bibliographic Details
Main Authors: Caineng Cao, Le Wang, Feng Jiang, Qifeng Jin, Ting Jin, Shuang Huang, Qiaoying Hu, Yuanyuan Chen, Yongfeng Piao, Yonghong Hua, Xinglai Feng, Yi Zhou, Xiaozhong Chen
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Glioblastoma
Hypofractionated radiotherapy
Temozolomide
Immunotherapy
GM-CSF
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558625000351
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items